Ireland
--:--IST
Latest
Recruiting Observational

Patients With Severe Acute Exacerbation of COPD Ans Admitted in ICU Register.

NCT06257329 · tracked via the Priya Life Science France tracker
Sponsor
Alexis FERRE
Phase
Observational
Started
2022-10-01
Last updated
2024-02-13

Condition(s) studied

COPD Exacerbation

Investigational drug(s) / intervention(s)

register

register: Multicentre prospective observational register

Study summary

The objective of this prospective observational study is to describe the epidemiological, clinical and biological characteristics of admitted patients in ICU for severe acute exacerbation of COPD, to assess the different therapeutics used, to evaluate the prognosis of patients with short, medium and long term ( 1 year) and the various factors associated with survival in ICU

Eligibility

Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥ 40 years old 2. COPD documented or strongly suspected * Chronic respiratory symptoms (dyspnoea, cough and/or sputum) * Exposure to a known risk factor for COPD (such as tobacco smoke) * If available, respiratory function tests showing non- or partially reversible obstructive syndrom (post-bronchodilator ratio FEV1/CV \< 0.7) 3. Severe acute exacerbation, defined as a worsening of the patient's usual respiratory symptoms with signs of acute respiratory distress (polypnoea ≥ 30 cycles.min-1 or use of accessory respiratory muscles) and/or hypercapnic acidosis (with PaCO2 ≥ 45 mmHg and pH ≤ 7.35) 4. Admission to an ICU, a step-up unit or a respiratory care unit Exclusion Criteria: 1. Known asthma (according to the criteria of the international "Global initiative for asthma" guidelines) 2. Patient refusal to participate (information note, application for non-opposition)

Primary outcome measure(s)

  • the epidemiological, clinical and biological characteristics of patients admitted to the ICU for a severe acute exacerbation of COPD — 5 year
    to describe the epidemiological, clinical and biological characteristics of patients admitted to the ICU for a severe acute exacerbation of COPD

Trial sites (2)

FacilityCityRegionStatus
Centre hospitalier de Versailles Le Chesnay France Recruiting
CH Le Mans Le Mans France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06257329 on ClinicalTrials.gov ↗ ← All trials in France